Life Sciences Legislation And Regulation To Watch In 2016

Law360, New York (December 24, 2015, 8:38 PM EST) -- When legislative and regulatory activity picks up again in 2016, the federal government will have important life sciences issues on its plate, from prescription drug pricing to the 21st Century Cures Act.

But what actually gets done in the life sciences arena will be dramatically influenced by the upcoming presidential election, experts say.

Controversial laws, rules and guidances will become more difficult to finalize, as campaigning ramps up and incumbents running for re-election or a different office are less likely to take a stance that could...
To view the full article, register now.